Abstract
Lipocalin-2 (Lcn2) is an innate immune peptide with pleiotropic effects. Lcn2 binds iron-laden bacterial siderophores, chemo-attracts neutrophils and has immunomodulatory and apoptosis-regulating effects.
In this study we show that upon infection with Salmonella enterica serovar Typhimurium, Lcn2 promotes iron export from Salmonella-infected macrophages, which reduces cellular iron content and enhances the generation of pro-inflammatory cytokines. Lcn2 represses IL-10 production while augmenting Nos2, TNF-α and IL-6 expression. Lcn2-/- macrophages have elevated IL-10 levels as a consequence of increased iron content. The crucial role of Lcn-2/IL-10 interactions was further demonstrated by the greater ability of Lcn2-/- IL-10-/- macrophages and mice to control intracellular Salmonella proliferation in comparison to Lcn2-/- counterparts. Over-expression of the iron exporter ferroportin-1 in Lcn2-/- macrophages represses IL-10 and restores TNF-α and IL-6 production to the levels found in wild-type macrophages, so that killing and clearance of intracellular Salmonella is promoted.
Our observations suggest that Lcn2 promotes host resistance to Salmonella Typhimurium infection by binding bacterial siderophores and suppressing IL-10 production, and that both functions are linked to its ability to shuttle iron from macrophages.
Keywords: Lipocalin-2, iron, macrophage, IL-10, Salmonella
Introduction
Salmonella enterica serovar Typhimurium is a Gram-negative facultative intracellular pathogenic bacterium that replicates within macrophages and requires iron to exert full virulence and to establish infection [1, 2]. To gain sufficient access to iron within the host, Salmonella Typhimurium utilizes several acquisition systems. On the one hand, Salmonella Typhimurium produces siderophores which capture iron from host proteins due to their extraordinarily high affinity for the metal. In iron-limiting conditions, Salmonella synthesizes enterobactin, its prototypical catecholate-type siderophore, by a multi-step process involving EntC (isochorismate synthetase). Following secretion, iron-laden catecholate-type siderophores are bound by receptors on the outer membrane of Salmonella [3-6]. On the other hand, non-siderophore bound ferrous iron is taken up by the Feo and Sit systems, respectively [7-10]. Both siderophore-dependent and -independent pathways of iron acquisition are up-regulated upon infection and are linked to Salmonella virulence.
While promoting the replication of most viral, bacterial, fungal and protozoan pathogens, iron exerts diverse effects on immune cells thus influencing several aspects of the host-microbe interplay [11-14]. Iron inhibits the production of TNF-α and reactive nitrogen species (RNS) as it inhibits the transcription of NO synthase (Nos)-2 [15]. In contrast, the generation of ROS by Fenton/Haber-Weiss chemistry requires iron as essential cofactor.
The host has evolved numerous strategies to counteract microbial iron acquisition [11, 16]. In the setting of acute infection, the extracellular space is depleted of iron [17, 18], which is retained in cells of the mononuclear phagocyte system (MPS) and sequestered within the iron-storage protein ferritin (Ft) [15, 19-22]. In parallel, the antimicrobial peptide hepcidin-1 (Hamp1) is produced during inflammation [23, 24]. Hamp1 targets ferroportin-1 (Fpn1) and induces its internalization from the cell surface membrane, which subsequently results in Fpn-1 degradation and reduction of cellular iron efflux [25]. As a consequence, duodenal iron absorption and iron recycling from the MPS are hampered, which reduces serum iron levels. This mechanism is thought to be beneficial in the presence of extracellular bacteria by limiting their excess to the nutrient iron [15, 16, 26, 27]. Upon infection of macrophages with intracellular microbes, however, Hamp1-induced Fpn1-internalization is counter-productive as this mechanism increases the intracellular iron content and facilitates iron access for pathogens within infected cells [28]. Consequently, inhibition of Hamp1 formation improves host defense against Salmonella [29]. Nos2 mediates the induction of Fpn1 transcription in macrophages infected with Salmonella Typhimurium, thus counter-balancing Hamp1 function [30].
Further, the multi-functional protein lipocalin-2 (Lcn2) is released by monocytic cells to limit the availability of iron for invading microbes. In its primary role, Lcn2 captures bacterial siderophores including enterobactin produced by Salmonella Typhimurium and other enterobacteriaceae such as Escherichia coli and Klebsiella pneumoniae [31-33] as well as carboxymycobactins generated by mycobacteria [34-36].
Second, Lcn2 affects mammalian iron homeostasis by siderophore-dependent processes. Lcn2 binds iron-laden siderophores, thus mediating iron uptake via Lcn2 receptor (LcnR). On the other hand, iron-free siderophores can be imported through LcnR-mediated endocytosis. Intracellularly, these apo-siderophores bind iron for subsequent LcnR-dependent export. In cells over-expressing LcnR, this mechanism causes iron depletion and induces apoptosis [37]. In addition, mammalian siderophores have been identified [38, 39], which may fulfill central functions in mammalian iron homeostasis including the regulation of cytoplasmic iron levels [40].
Third, Lcn2 promotes the production of the chemokine IL-8 and, independently, stimulates the chemotaxis of neutrophils by an ERK1/2-mediated mechanism [41, 42].
While the role of Lcn2 in neutrophils and in Salmonella enterocolitis is well established [42-44], little is known about its function in macrophages and in the course of Salmonella septicemia. We therefore systematically investigated the role of Lcn2 in the setting of Salmonella Typhimurium infection and observed that Lcn2 production has distinct effects on macrophage iron homeostasis and immune response.
Lcn2-/- mice infected with Salmonella had higher bacterial burdens in spleen and liver due to a shift of the immune response towards an anti-inflammatory phenotype characterized by increased IL-10 levels and reduced expression of Nos2, TNF-α and IL-6. Furthermore, Lcn2-/- macrophages had increased cellular iron content and produced higher amounts of IL-10, which could be reversed by the iron chelator deferasirox (DFX) or upon over-expression of the iron exporter FPN1. Increased IL-10 production played a central role in the immune dysfunction of Lcn2-/- macrophages as its neutralization restored the generation of NO and TNF-α. The high IL-10 production contributed to the poor control of Salmonella by Lcn2-/- macrophages, as Lcn2-/- IL10-/- macrophages killed Salmonella substantially better than IL-10-producing Lcn2-/- cells.
The findings presented herein expand our knowledge on the pleiotropic immune-regulatory effects of Lcn2. Lcn2 limits macrophage iron content and IL-10 production thus ensuring efficient host defense against Salmonella Typhimurium. Therefore, Lcn2 links the maintenance of macrophage iron homeostasis to their antibacterial effector functions.
Results
Lcn2 regulates macrophage iron content upon Salmonella Typhimurium infection
Upon infection of thioglycolate-elicited peritoneal macrophages with Salmonella Typhimurium, we observed a time-dependent massive increase of Lcn2 mRNA levels (Fig. 1A). The induction of Lcn2 mRNA became highly significant as early as 1.5 h after Salmonella infection and peaked after 18 h. To study a potential influence of Lcn2 on macrophage iron homeostasis, we isolated thioglycolate-elicited peritoneal macrophages from Lcn2-/- mice on a C57BL/6 background and from Lcn2+/+ littermates. At 24 h after infection with Salmonella Typhimurium (S. Tm.), primary Lcn2-/- macrophages had increased iron contents as compared to their wild-type (wt) counterparts (Fig. 1B). This was attributable to impaired iron export from Lcn2-/- macrophages (Fig. 1C), while iron import was not different between Lcn2-/- and Lcn2+/+ macrophages (data not shown). In line, the number of intracellular Salmonella was significantly higher in Lcn2-/- than in Lcn2+/+ macrophages after 24 h (Fig. 1D), whereas no difference was observed in Salmonella uptake by macrophages after 30 min (Fig.1E).
Increased IL-10 mRNA expression in Lcn2-/- macrophages
Given the higher iron content of Lcn2-/- peritoneal macrophages and the known influence of iron on macrophage functions, we tested the regulation of immune response genes as a function of Lcn2 expression over time. Following infection with Salmonella Typhimurium, we observed that as early as 3 h after the initiation of infection, Lcn2-/- macrophages (open symbols) expressed higher IL-10 mRNA levels as compared to their wt counterparts (Fig.2A, closed symbols). In contrast, TNF-α mRNA expression was significantly lower in infected macrophages from Lcn2-/- than from wt mice over time, which was also true of IL-6 and Nos2 expression at several but not all time points investigated (Fig. 2B, C and D). The increased IL-10 mRNA levels observed in Lcn2-/- macrophages translated into increased IL-10 concentrations in culture supernatants of Salmonella-infected Lcn2-/- macrophages (Fig. 2E).
The enhanced production of IL-10 in Lcn2-/- macrophages appeared to be independent from TNF-α expression as the neutralization of TNF-α with a specific antibody did not alter the differences in bacterial killing or IL-10 secretion between peritoneal macrophages isolated from Lcn2-/- or wt mice (Supporting Information Fig. 1A and B). The accumulation of nitrite in culture supernatants, which was significantly dependent on the Lcn2 genotype in cells treated with the isotype control antibody, was reduced by the TNF-α antibody in both Lcn2-/- and wt macrophages ( Supporting Information Fig. 1C). Notably, exposure of macrophages to the same number of heat-inactivated Salmonella did not cause substantial differences in IL-10 mRNA expression between cells of the two genotypes (Fig. 2F). The influence of Lcn2 deficiency on macrophage IL-10 expression was not secondary to an increased bacterial load, as infection of macrophages with entC sit feo or aro mutant Salmonella, which are compromised in replication due to targeted defects in iron uptake or synthesis of aromatic amino acids, respectively, also resulted in a significant difference in IL-10 mRNA production (data not shown).
Furthermore, the effect was independent of the presence of other bacterial pathogenicity genes such as invA, Salmonella pathogenicity island (SPI)-1, SPI-2 or phoP, as infection of wt and Lcn2-/- macrophages with Salmonella strains deficient in these genes did not abolish the differences in IL-10 mRNA expression (data not shown). This was also true for infection with Salmonella carrying a mutation of lipid A (waaN mutant) or flagellin (fliC fljB mutant) biosynthesis, which results in reduced stimulation of TLR4 and TLR5, respectively (Fig. 3A).
In contrast, stimulation with TLR ligands MALP-2, PAM2Cys, PAM3Cys, Poly:ICs, LPS and flagellin did not result in significantly different IL-10 mRNA or protein expression between macrophages of the two genotypes (Fig. 3A and 3B and data not shown). Interestingly, infection with the intracellular pathogens Chlamydia pneumoniae or Listeria monocytogenes also resulted in increased IL-10 mRNA and protein expression by Lcn2-/- macrophages, whereas challenging of macrophages with the extracellular bacteria E. coli or Klebsiella pneumoniae did not cause differences in IL-10 mRNA expression between wt and Lcn2-/- macrophages. Exposure of macrophages to Staphylococcus aureus resulted in reduced IL-10 mRNA and protein levels in Lcn2-/- as compared to wt macrophages (Fig. 3C and 3D).
Exposure to Salmonella Typhimurium resulted in differential IL-10 expression between wt and Lcn2-/- macrophages. However, the addition of cytochalasin D (CytD) which inhibits the internalization of bacteria (and was effective as determined by selective plating) as well as actin cytoskeletal rearrangements did not affect this differential IL-10 production (Fig. 3E and data not shown).
As Lcn2 has been implicated in the control of apoptosis, we performed additional in vitro experiments to look for differences in cell death between Salmonella-infected wt and Lcn2-/- macrophages. However, we did not see significant differences in annexin V or propidium iodide staining, or caspase-1 activation ( Supporting InformationFig. 2A, B and C). Furthermore, IL-1β secretion, another indicator of caspase-1 activity, was not different between wt and Lcn2-/- macrophages (data not shown).
Low intracellular iron suppresses IL-10 and restores effector functions in Lcn2-/- macrophages
In view of the increased iron content of Lcn2-/- peritoneal macrophages, we tried to rescue the phenotype of Lcn2-/- cells by forced expression of the iron exporter FPN1 in macrophages. We saw that transfection of wt (Fig. 4A, closed bars) and Lcn2-/- macrophages (Fig. 4A, open bars) with WT FPN1 and the FPN1 N144H variant (conferring partial resistance to Hamp1) significantly increased iron release from both cells and abrogated the differences observed between these two genotypes, both at steady state conditions and after infection with Salmonella. In contrast, expression of the FPN1 A77D mutant, which is retained in the cytoplasm, was without any effect. Furthermore, the differences in bacterial load and IL-10 secretion between wt and Lcn2-/- peritoneal macrophages were specifically abrogated by over-expression of WT FPN1 and the FPN1 N144H variant in these macrophages (Fig. 4B and C). In contrast, over-expression of the FPNA77D variant, which is unable to mount transcellular iron export due to its intracellular retention, had no effect. Similarly, treatment of infected macrophages with the iron chelator DFX significantly reduced IL-10 secretion and bacterial loads in wt and Lcn2-/- macrophages and abrogated the differences between the two genotypes (Fig. 4D and E).
To confirm that the increased expression of Fpn1 is related to improved control of infection with Salmonella, we used constructs coding for FPN1-EmGPF fusion proteins to rescue Lcn2-/- peritoneal macrophages (Fig. 5). At a transfection rate of 71 ± 5% we were able to assess the intracellular bacterial load in GFP+ cells over-expressing FPN1 and compare it to the bacterial load observed in un-transfected GFP- macrophages not over-expressing FPN1 (Fig. 5B, D and F). Over-expression of FPN1 resulted in improved control of infection in GFP+ macrophages (Fig. 5B) as reflected by low or no bacterial counts in these cells whereas GFP- macrophages harbored more bacteria after 16 h of infection (see Fig. 5B and compare GFP+ and GFP- cells in Fig. 5D and F). In addition, the over-expression of FPN1 in GFP+ Lcn2-/- cells rescued their phenotype (Fig. 5B and F), whereas transfection with a control plasmid encoding EmGFP but not FPN1 did not show this effect (Fig. 5A and E).
Targeting IL-10 rescues the phenotype of Lcn2-/- macrophages and mice
To study the functional consequence of differential expression of the anti-inflammatory mediator IL-10 between wt and Lcn2-/- macrophages, we infected cells in the presence and absence of neutralizing antibody against IL-10 or CD-210, a subunit of the IL-10 receptor. Either antibody abrogated the differences in bacterial load (Fig. 6A) and NO output (Fig. 6B) between wt and Lcn2-/- macrophages. While antibody-mediated blockade of IL-10 signaling promoted TNF-α generation in both wt and Lcn2-/- macrophages (Fig. 6C), the differences between cells of the two genotypes were not fully eliminated. Importantly, we found that Lcn2-/- IL-10-/- thioglycolate-elicited peritoneal macrophages controlled Salmonella Typhimurium significantly better than Lcn2-/- (i.e., Lcn2-/- IL-10+/+) cells (Fig. 6D). Similar effects of Lcn2 on bacterial loads and IL-10 production were observed in non-elicited previously naïve peritoneal macrophages. Moreover, bacterial loads in infected BMDM from Lcn2-/- IL-10-/- mice were comparable to that from IL-10-/- mice ( Supporting Information Fig. 3A-3D).
We then looked for differences in the immune response between wt and Lcn2-/- mice upon systemic Salmonella Typhimurium infection. Of note, Lcn2-/- mice infected with Salmonella harbored significantly more bacteria in spleen and liver (Fig. 7A and data not shown) and had increased IL-10 mRNA levels in the spleen as compared to wt mice (Table 1). This translated into increased IL-10 serum concentrations (Fig. 7B). In contrast, mRNA levels of Nos2, TNF-α and IL-6 were substantially reduced in the spleen of Salmonella-infected Lcn2-/- mice (Table 1). Correspondingly, serum TNF-α and IL-6 concentrations were lower in Lcn2-/- mice (Fig. 7C and 7D).
Table 1. Relative mRNA expression of splenic immune genes 72 h after onset of Salmonella Typhimurium (S. Tm.) infection in wt and congenic Lcn2-/- mice.
Stimulation Gene name | Control wt (Lcn2+/+) | Control Lcn2-/- | S. Tm. wt (Lcn2+/+) | S. Tm. Lcn2-/- |
---|---|---|---|---|
IL-10 [AU] | 0.84 ± 0.73 | 1.13 ± 1.19 | 4.16 ± 3.52 a | 40.63 ± 8.77 b,c |
Nos2 [AU] | 0.06 ± 0.03 | 0.08 ± 0.06 | 19.06 ± 7.03 a | 6.27 ± 2.69 b,c |
p47-phox [AU] | 5.33 ± 1.91 | 4.82 ± 2.71 | 23.45 ± 6.53 a | 25.51 ± 11.40 b |
TNF-α [AU] | 3.69 ± 1.82 | 4.14 ± 3.08 | 164.30 ± 27.90 a | 40.47 ± 22.49 b,c |
IL-1β [AU] | 13.02 ± 6.53 | 18.93 ± 9.46 | 180.20 ± 69.45 a | 139.99 ± 92.89 b |
IL-4 [AU] | 0.42 ± 1.00 | 0.65 ± 0.57 | 4.95 ± 7.03 a | 4.27 ± 1.71 b |
IL-6 [AU] | 0.35 ± 0.12 | 0.39 ± 0.19 | 11.70 ± 5.37 a | 6.82 ± 6.10 b,c |
IL-17A [AU] | 0.01 ± 0.00 | 0.02 ± 0.01 | 9.06 ± 11.10 a | 8.92 ± 4.38 b |
IFN-γ [AU] | 2.06 ± 2.86 | 0.88 ± 1.21 a | 39.74 ± 45.13 a | 19.61 ± 33.67 b |
P < 0.05 as compared to uninfected (Ctrl.) wt (Lcn2+/+) mice.
P < 0.05 as compared to uninfected (Ctrl.) Lcn2-/- mice.
P < 0.05 for comparison of S. Tm.-infected wt (Lcn2+/+) and S. Tm.-infected Lcn2-/- mice.
AU… arbitrary units of target gene expression relative to the level of the housekeeping gene Hprt.
Importantly, treatment with a neutralizing monoclonal IL-10 antibody (α IL-10; depicted as grey circles in Fig. 7E) could to a large degree rescue the phenotype of Lcn2-/- mice (open circles) resulting in significantly lower splenic bacterial loads than observed in Lcn2-/- mice treated with solvent (PBS) or a non-neutralizing IgG control antibody (isotype). There was no difference in the bacterial load in the spleen of solvent-treated wt mice (closed circles) as compared to α IL-10 treated Lcn2-/- mice (Fig. 7E). Furthermore, in the spleen, the bacterial load in Lcn2-/- IL-10-/- mice (grey circles) was significantly lower than in Lcn2-/- mice (open circles) and not different from wt mice (Fig. 7F, closed circles). This difference was paralleled by increased TNF- α and IL-6 serum levels in Lcn2-/- IL-10-/- mice as compared to Lcn2-/- mice (Supporting Information Fig. 4A and 4B).
In addition, mice were infected with wt Salmonella Typhimurium or an isogenic entC mutant unable to produce any catecholate-type siderophores. The bacterial load in liver (not shown) and spleen (Fig. 7G) was lower in wt (closed symbols) than in Lcn2-/- mice (open symbols) 72 h after bacterial injection, independent of the capacity of Salmonella to produce catecholate-type siderophores. Thus, in the absence of siderophore production by Salmonella, Lcn2-/- mice continued to display higher bacterial load than wt mice (Fig. 7G) paralleled by increased serum IL-10 levels (data not shown).
Discussion
In being an essential cofactor for numerous processes in both mammalian and microbial metabolism, iron plays a central role in host-pathogen interactions [12, 14, 45]. In the classical view, the immune response in the course of a bacterial infection directs iron fluxes into the MPS and results in the safe sequestration of iron within Ft [11, 15, 16]. This diversion of iron trafficking renders iron unavailable for extracellular pathogens and is driven by pro-inflammatory cytokines that stimulate iron uptake and Ft expression, and by Hamp1, which stops Fpn1-mediated iron export [25, 29].
Lcn2 has initially been described as a granule-derived secretion product of neutrophils [46, 47]. However, little is known about the interactions of neutrophils and iron homeostasis under either steady state conditions or during infections. Lcn2 is generated by a range of cell types including macrophages. We therefore studied the regulation of iron metabolism upon infection with a facultative intracellular bacterium, Salmonella Typhimurium, which invades monocytes and macrophages in order to spread systemically within MPS organs of the host [1]. We report that the antimicrobial peptide Lcn2 exerts essential regulatory functions in macrophage iron homeostasis and is required for an efficient pro-inflammatory immune response in the setting of Salmonella Typhimurium infection. The induction of Lcn2 synthesis following Salmonella infection was required to limit the macrophage iron content upon Salmonella infection. Furthermore, Lcn2-/- mice and macrophages were characterized by a shift of the immune response to an anti-inflammatory phenotype dominated by increased production of IL-10. The increased IL-10 expression of Lcn2-/- macrophages was a consequence of intracellular iron accumulation in these cells and could be reversed by the addition of the iron chelator DFX or by forced expression of functional FPN1 variants. In contrast, blockade or supplementation of TNF-α could not alter the differences in IL-10 production between wt and Lcn2-/- macrophages. Furthermore, the enhanced generation of IL-10 by Lcn2-/- macrophages was relevant for the outcome of Salmonella infection, as antibody-mediated neutralization of IL-10 or blockade of its specific receptor subunit CD-210 resulted in improved control of bacterial replication and restored the production of NO to levels observed in wt macrophages. The differences in TNF-α production between wt and Lcn2-/- cells could not be completely abolished by IL-10 blockade, suggesting the involvement of additional signaling events. Time-course experiments conducted with both viable and heat-inactivated Salmonella support the idea that increased IL-10 expression by Lcn2-/- macrophages is an early feature of the dysregulation of the immune response in these cells, while reduced Nos2 expression is the consequence. Thus, by repressing IL-10 production, Lcn2 may amplify the antimicrobial defense against Salmonella Typhimurium. Similar results were seen upon infection with the intracellular bacteria Chlamydia pneumoniae [48] or Listeria monocytogenes (Fig. 3 of this study).
Following infection with Streptococcus pneumoniae, Lcn2 has been identified as marker of deactivated macrophages, and Lcn2-/- BMDM generated reduced IL-10 mRNA levels [49]. This goes along with our observation that IL-10 production was reduced upon challenge of Lcn2-/- macrophages with the Gram-positive bacterium Staphylococcus aureus.
Cytochalasin D, an inhibitor of actin polymerization known to interfere with phagocytosis and cytoskeletal rearrangements, resulted in a dose-dependent increase in IL-10 secretion by Salmonella-exposed macrophages without affecting the relative differences observed between wt and Lcn2-/- macrophages. Given that infection of macrophages with E. coli or Klebsiella pneumoniae, both of which are enterobactin-producing (Gram-negative) enterobacteriaceae with a predominantely extracellular life cycle, did not result in differential IL-10 secretion by wt and Lcn2-/- macrophages, this result is somewhat unexpected (Fig. 3). Furthermore, we did not observe differences in IL-10 mRNA levels between wt and Lcn2-/- macrophages or spleens under non-inflammatory conditions (Table and details not shown). This implies that the basal transcription rate of the IL-10 gene in steady-state is not influenced by Lcn2 whose levels are readily detectable in the culture supernatant or serum in that situation though (details not shown). However, the presence of extracellular Salmonella may stimulate IL-10 secretion by a yet unknown mechanism that is counter-regulated by Lcn2 resulting in increased IL-10 production by Lcn2-/- macrophages (Fig. 3). Furthermore, the professional intracellular pathogens Chlamydia pneumoniae and Listeria monocytogenes (along with intracellular Salmonella Typhimurium) may stimulate IL-10 secretion by host macrophages when Lcn2 is absent. This suggests that the signaling pathway responsive to these unrelated intracellular bacteria is influenced by either Lcn2 itself or - indirectly - by intracellular iron which is higher in Lcn2-/- macrophages (Fig. 1). The idea that the mechanism is iron-dependent is supported by the results obtained with macrophages overexpressing functional FPN1 or being iron-depleted upon DFX treatment (Fig. 4). The dose-response effect of cytochalasin D on IL-10 secretion by both wt and Lcn2-/- macrophages further suggests that extracellular Salmonella carries a membrane component or produces a soluble mediator that stimulates IL-10 expression in a Lcn2-independent fashion or that signaling processes induced by extracellular Salmonella impact on IL-10 expression in that setting. However, based on the data obtained with purified LPS or flagellin, respectively (Fig. 3), and with Salmonella mutants this mechanism appears to be independent from classical TLR4- and TLR5 inducible signaling cascades. Additionally, we have ruled out the Salmonella pathogenicity island (SPI)-2 and phoP/phoQ systems are involved in this macrophage response using specific Salmonella mutants (data not shown). Therefore, it is likely that other PAMPs and PRRs mediate the increased IL-10 expression observed in Lcn2-/- macrophages in the setting of Salmonella infection.
Alternatively, an actin-dependent endocytotic mechanism preferentially involved in the response to intracellular pathogens may inhibit IL-10 secretion by infected macrophages because blockade of endosomal trafficking is associated with impaired control of Salmonella replication within macrophages [50]. Either way, further studies will be required to precisely define the signaling pathways that link Lcn2 to IL-10 transcription in macrophages confronted with intracellular bacteria.
A growing number of reports demonstrate that Lcn2 is important in the control of pathogens that do not produce siderophores or whose siderophores cannot be captured by Lcn2 [48]. These pathogens controlled by Lcn2 by siderophore-independent mechanisms include Chlamydia pneumoniae, Staphylococcus aureus and Candida albicans. Moreover, differences in serum iron levels between wt and Lcn2-/- mice following challenge with pure LPS have been reported [51]. We observed that there is a significant difference in the number of entC mutant Salmonella Typhimurium in liver and spleen of wt as compared to Lcn2-/- mice. This is of interest as the entC mutant is unable to synthesize the Lcn2 target enterobactin. These results thus imply a dual mechanism by which Lcn2 combats infection with Salmonella Typhimurium. One mechanism is the interference of Lcn2 with enterobactin-mediated bacterial iron acquisition. The importance of this host iron restriction strategy is evident from the comparison of the bacterial load of wt vs. entC mutant Salmonella Typhimurium. Second, there is a Lcn2-mediated antibacterial mechanism that is independent of its ability to bind bacterial siderophores. Our data obtained with antibody-mediated neutralization of circulating IL-10 and with Lcn2-/- IL-10-/- mice suggest that this mechanism is mediated via IL-10. We therefore conclude that in the course of infection with Gram-negative bacteria, Lcn2 also functions as a negative regulator of IL-10 by mediating cellular iron export. Lcn2 thus links the maintenance of iron homeostasis in macrophages to an efficient pro-inflammatory and antimicrobial immune response, which is of pivotal importance in host resistance to Salmonella Typhimurium infection.
Materials and Methods
Cell isolation and culture
C57BL/6N type mice (wt, Lcn2+/+), congenic Lcn2-/- mice [31], IL-10-/- mice and Lcn2-/-IL-10-/- mice, backcrossed onto a C57BL/6N background for at least 12 generations, were used in these studies. To generate Lcn2-/-IL-10-/- mice, IL-10-/- mice [57] were obtained (The Jackson Laboratory) and intercrossed with Lcn2-/- mice. Following genotyping, littermates were housed in neighbouring cages under specific pathogen-free conditions at the central animal facility of the Medical University of Innsbruck.
Thioglycolate-elicited or non-elicited naïve peritoneal macrophages were harvested from Lcn2+/+ C57BL/6N and congenic Lcn2/- mice, IL-10-/- mice or Lcn2-/-IL-10-/- mice, respectively, and cultured as detailed elsewhere [30]. BMDM were harvested from tibiae and femora and cultured for 7 days in the presence of 50 ng/ml recombinant murine M-CSF (Preprotech). Macrophages were incubated in RPMI and stimulated with phosphate buffered saline (PBS; Lonza), 100 ng/ml LPS (lipopolysaccharide from Salmonella Typhimurium used as a TLR4 ligand; Sigma-Aldrich), 1 μg/ml MALP-2 (macrophage-activating lipopeptide from Mycoplasma fermentans used as a TLR2/6 ligand; Alexis), 100 ng/ml Pam2Cys (TLR2/6 ligand; EMC microcollections), 100 ng/ml Pam3Cys (used as TLR1/2 ligand; purchased from EMC microcollections), 10 μg/ml Poly(I:C) (TLR3 ligand; Sigma-Aldrich) or 100 ng/ml flagellin (from Salmonella Typhimurium; TLR5 ligand; Enzo) .
The purity of the resulting cell suspension was tested by fluorescent-activated cell sorting analysis and exceeded 95% [58]. Intracellular iron concentrations in macrophages were determined by atomic absorption as described [58].
For macrophage iron export assays, cells were treated and infected with S. Typhimurium as detailed above and iron export determined with 5 μM 59Fe-citrate exactly as previously described [30]. In parallel to each iron release study, a trypan-blue exclusion assay was performed to ensure that neither treatment interfered with macrophage integrity and viability.
Salmonella infection in vitro
Prior to in vitro infection, macrophages were extensively washed with PBS and incubated in complete RPMI without antibiotics. Unless otherwise indicated, wt Salmonella enterica serovar Typhimurium (S. Typhimurium) strain ATCC14028 was used for experiments and grown under sterile conditions in LB broth (Sigma-Aldrich) to late-logarithmic phase. Macrophages were infected with S. Typhimurium at a multiplicity of infection (MOI) of 10 for 1 h. Thereafter, cells were washed with PBS and incubated in complete RPMI containing gentamicin (Gibco). Where appropriate, cells were subsequently treated with 50 μM deferasirox (DFX; Novartis), a monoclonal rat anti-mouse IL-10 antibody (10 μg/ml; clone JES5-2A5), a monoclonal rat anti-mouse CD-210 antibody (10 μg/ml; clone 1B1.3a), a monoclonal rat anti-mouse TNF-α antibody (10 μg/ml; clone MP6-XT22), or the appropriate isotype controls (10 μg/ml; all from Biolegend) for up to 23 h. Where appropriate, cells were preincubated in 0.1 to 50 μg/ml cytochalasin D (CytD; Sigma-Aldrich) 1 hr prior to the infection.
To determine intracellular bacterial loads, infected cells were harvested in 0.5% sodium deoxycholic acid (Sigma-Aldrich) as described [52]. To determine bacterial uptake, infected cells were harvested after 30 min.
Isogenic S. Typhimurium mutants used included entC(x02237)aph, entC:aph sit(x02237)bla feo(x02237)Tn10 (Tet), fepA(x02237)FRTcatFRT, iroN(x02237)FRTkanFRT, invA(x02237)aph, SPI-1(x02237)aph, SPI-2(x02237)kan, rpoE(x02237)cat, phoP102(x02237)Tn10dCm, aroA(x02237)Tn10, waaN(x02237)FRTkanFRT and fliC(x02237)cat fljB(x02237)Tn10 [1, 3, 52].
Where indicated, Escherichia coli (ATCC 25922), Klebsiella pneumoniae (ATCC 43816), Listeria monocytogenes EGDe (ATCC BAA-679; kindly provided by Thomas Decker, Max F. Perutz Laboratories, Department of Genetics, Microbiology and Immunobiology, University of Vienna, Austria) or Staphylococcus aureus (ATCC 11632) were used for in vitro infections at a MOI of 10:1. The Chlamydia pneumoniae strain CV-6 (kindly provided by Jan Rupp, Institute of Medical Microbiology and Hygiene, University of Lübeck, Germany) was cultivated and propagated as described earlier, and infections were performed at a MOI of 10:1 [53].
Plasmids and transient transfection
Human FPN1 and the N144H (conferring partial resistance to Hamp1) and A77D FPN1 (resulting in reduced cell surface expression) mutants, respectively, were cloned into the p-cDNA3.1 expression vector as described elsewhere and kindly provided by Mrs. Lisa Schimanski and Dr. Hal Drakesmith, Weatherall Institute of Molecular Medicine, Oxford, United Kingdom [59]. Transient transfections of primary peritoneal macrophages were performed by means of lipofection using Lipofectamine (Promega).
For immunocytochemistry, we used EmGFP N- or C-terminally tagged human FPN1 expression clones, kindly provided by Dr. Heinz Zoller, Department of Internal Medicine II, Medical University of Innsbruck, Austria [60]. The FPN1 open reading sequence was transferred into Vivid Colors pcDNA 6.2/EmGFP-DEST vectors to create EmGFP FPN1 expression clones. As control vectors, we used Vivid Colors pcDNA 6.2 EmGFP/CAT (chloramphenicol acetyltransferase) plasmids. Efficiency of transfections was at least 71±5%. The use of EmGFP-FPN1 fusion constructs thus allows the determination of the bacterial load at the single-cell level and the direct comparison of cells overexpressing FPN1 (transfected and thus GFP+) and cells not overexpressing FPN1 (un-transfected and thus GFP-). Thus, the intracellular Salmonella load can be analyzed as a function of FPN1 expression.
peritoneal macrophages were seeded on glass slides, transfected and subsequently infected for 16-24 h as described [30]. Cells were incubated with antibodies as follows: a chicken GFP antibody (1:1000; Invitrogen), a goat CSA1 (for Salmonella common structural antigen) antibody (1:1,000; KPL) and appropriate fluorochrome-conjugated secondary antibodies, i.e., rabbit anti-chicken Alexa Fluor 488 (green; 1:1,000; Dianova) and donkey anti-goat Alexa 594 (red; 1:1,000; Invitrogen). In independent experiments, cells were stained with annexin V (BioLegend) or propidium iodide (Sigma) according to the manufacturer's recommendations. For microscopic analysis, cells were covered with Fluorescent Mounting Medium (DAKO) containing DAPI and analyzed under an Axioskop 2 microscope (Carl Zeiss). Acquisition was done using the Carl Zeiss AxioCam MRc 5 camera, a 100×/1.25 objective and AxioVision imaging software version 4.0.
Salmonella infection in vivo
All animal experiments were performed according to the guidelines of the Medical University of Innsbruck based on the Austrian Animal Testing Act of 1988. All animal experiment protocols were approved by the ‘MUI Animal ethics committee’ and the Austrian Ministry for Science and Education (approvals no. BMWF-66.011/0072-II/3b/2012 and no. BMWF-66.011/0142-WF/V/3b/2014). Unless otherwise indicated, male mice were used at 12-16 weeks of age and infected i.p. with 500 CFU of S. Typhimurium diluted in 200 μl PBS. Unless otherwise specified, S. Typhimurium wt strain ATCC 14028s was used for experiments. In some experiments, its isogenic mutant derivative entC(x02237)aph was used. This mutant strain was constructed and grown as described [3] and used as detailed above. The bacterial load of organs was determined by plating serial dilutions of organ homogenates on LB agar (Sigma-Aldrich) under sterile conditions and the number of bacteria calculated per gram of tissue.
Where appropriate, mice were infected as above and injected i.p. 200 μg of the neutralizing monoclonal anti-mouse IL-10 antibody (clone JES5-2A5) dissolved in 200 μl PBS or the identical amount of an isotype control antibody (all obtained from Biolegend) on d 1 and 2 after infection. Mice were then sacrificed on d 3 of infection.
The determination of tissue iron content was carried out in a 96-well plate following acid hydrolysis at 65°C for 24 h and using a colorimetric solution containing sodium acetate, bathophenanthroline disulfonic acid and L-ascorbic acid. The calculated iron quantity was normalized to the wet tissue weight for each sample. Plasma iron concentration was quantified using a commercially available iron kit (QuantiChrom Iron Assay Kit; BioAssay Systems), exactly following the manufacturer's instructions. Monocyte and neutrophils counts were hemocytometrically quantified using a veterinary animal blood counter (Lab Technologies).
RNA extraction and quantitative real-time PCR
Total RNA was prepared and mRNA expression quantified by quantitative RT-PCR following reverse transcription exactly as described [52]. Hypoxanthine phosphoribosyltransferase (Hprt), β-glucuronidase, β-actin and 18s ribosomal RNA were used as housekeeping genes with similar results [54, 55]. Data are depicted and were analyzed using Hprt as reference gene.
Western blot analysis
Protein extraction and Western blotting were performed using a rat Lcn2 antibody (1:400; R&D), a rabbit Fpn1 antibody (1:400; Eurogentec), a rabbit actin antibody (1:1,000; Sigma-Aldrich) and appropriate HRP-conjugated secondary antibodies (1:1000; Dako).
Detection of cytokines and reactive species
Determination of cytokines in culture supernatants was performed with ELISA kits for TNF-α, IL-6 and IL-10 (BD Pharmingen). Determination of nitrite, the stable oxidation product of nitric oxide (NO), was carried out with the Griess-Ilosvay's nitrite reagent (Merck) as described [52].
Statistical analysis
Statistical analysis was carried out using a SPSS statistical package. We determined significance by unpaired two-tailed t test to assess data, when only two groups were compared. For multiple comparisons Analysis of variance (ANOVA) combined with Bonferroni correction was performed. Unless otherwise specified, data are depicted as lower quartile, median and upper quartile (boxes), and minimum/maximum ranges. When Gaussian distribution was not assumed, data were log-transformed prior to t test or ANOVA. Generally, P values less than 0.05 were considered significant in any test.
Supplementary Material
Acknowledgments
The authors are grateful to Sylvia Berger, Alexandra Bichler, Ines Brosch, Sabine Engl and Markus Seifert for excellent technical support.
The authors thank Dr. Shizuo Akira, Laboratory of Host Defense, Osaka University for providing Lcn2-/- mice [31].
The authors are indebted to Mrs. Lisa Schimanski and Drs. Thomas Decker, Hal Drakesmith, Jan Rupp and Heinz Zoller for providing bacteria and plasmids, respectively [53, 56].
This work was supported by grants from the Austrian Research Fund (FWF; project TRP-188 to G.W.), the ‘Theodor Körner Fonds’ (to M.N.), the intramural funding program of the Medical University Innsbruck for young scientists MUI-START (project 2012032003 to M.N.) and by the ‘Verein zur Förderung von Forschung und Weiterbildung in Infektiologie und Immunologie an der Medizinischen Universität Innsbruck’. F.F. is supported by the National Institutes of Health (AI39557 and AI44486).
Abbreviations
- ANOVA
analysis of variance
- CytD
cytochalasin D
- DFX
deferasirox
- Fpn1
ferroportin-1
- Ft
ferritin
- Hamp1
hepcidin antimicrobial peptide-1
- Lcn2
lipocalin-2
- LcnR
Lcn2 receptor
- MPS
mononuclear phagocyte system
- qRT-PCR
quantitative reverse-transcription polymerase chain reaction
Footnotes
Conflict of interest: The authors declare no commercial or financial conflict of interests.
References
- 1.Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, Brown W, Le M, et al. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature. 1999;401:804–808. doi: 10.1038/44593. [DOI] [PubMed] [Google Scholar]
- 2.Collins HL. The role of iron in infections with intracellular bacteria. Immunol Lett. 2003;85:193–195. doi: 10.1016/s0165-2478(02)00229-8. [DOI] [PubMed] [Google Scholar]
- 3.Crouch ML, Castor M, Karlinsey JE, Kalhorn T, Fang FC. Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol. 2008;67:971–983. doi: 10.1111/j.1365-2958.2007.06089.x. [DOI] [PubMed] [Google Scholar]
- 4.Nagy TA, Moreland SM, Andrews-Polymenis H, Detweiler CS. The Ferric Enterobactin Transporter Fep Is Required for Persistent Salmonella enterica Serovar Typhimurium Infection. Infect Immun. 2013;81:4063–4070. doi: 10.1128/IAI.00412-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hantke K, Nicholson G, Rabsch W, Winkelmann G. Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A. 2003;100:3677–3682. doi: 10.1073/pnas.0737682100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rabsch W, Voigt W, Reissbrodt R, Tsolis RM, Baumler AJ. Salmonella typhimurium IroN and FepA proteins mediate uptake of enterobactin but differ in their specificity for other siderophores. J Bacteriol. 1999;181:3610–3612. doi: 10.1128/jb.181.11.3610-3612.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tsolis RM, Baumler AJ, Heffron F, Stojiljkovic I. Contribution of TonB- and Feo-mediated iron uptake to growth of Salmonella typhimurium in the mouse. Infect Immun. 1996;64:4549–4556. doi: 10.1128/iai.64.11.4549-4556.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zhou D, Hardt WD, Galan JE. Salmonella typhimurium encodes a putative iron transport system within the centisome 63 pathogenicity island. Infect Immun. 1999;67:1974–1981. doi: 10.1128/iai.67.4.1974-1981.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Boyer E, Bergevin I, Malo D, Gros P, Cellier MF. Acquisition of Mn(II) in addition to Fe(II) is required for full virulence of Salmonella enterica serovar Typhimurium. Infect Immun. 2002;70:6032–6042. doi: 10.1128/IAI.70.11.6032-6042.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Janakiraman A, Slauch JM. The putative iron transport system SitABCD encoded on SPI1 is required for full virulence of Salmonella typhimurium. Mol Microbiol. 2000;35:1146–1155. doi: 10.1046/j.1365-2958.2000.01783.x. [DOI] [PubMed] [Google Scholar]
- 11.Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol. 2004;2:946–953. doi: 10.1038/nrmicro1046. [DOI] [PubMed] [Google Scholar]
- 12.Nairz M, Schroll A, Sonnweber T, Weiss G. The struggle for iron - a metal at the host-pathogen interface. Cell Microbiol. 2010;12:1691–1702. doi: 10.1111/j.1462-5822.2010.01529.x. [DOI] [PubMed] [Google Scholar]
- 13.Cairo G, Recalcati S, Mantovani A, Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol. 2011;32:241–247. doi: 10.1016/j.it.2011.03.007. [DOI] [PubMed] [Google Scholar]
- 14.Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012;338:768–772. doi: 10.1126/science.1224577. [DOI] [PubMed] [Google Scholar]
- 15.Weiss G. Iron and immunity: a double-edged sword. Eur J Clin Invest. 2002;32(Suppl 1):70–78. doi: 10.1046/j.1365-2362.2002.0320s1070.x. [DOI] [PubMed] [Google Scholar]
- 16.Weinberg ED. Iron availability and infection. Biochim Biophys Acta. 2009;1790:600–605. doi: 10.1016/j.bbagen.2008.07.002. [DOI] [PubMed] [Google Scholar]
- 17.Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69–85. doi: 10.1146/annurev.physiol.69.031905.164337. [DOI] [PubMed] [Google Scholar]
- 18.Ganz T. Macrophages and Systemic Iron Homeostasis. J Innate Immun. 2014;4:446–453. doi: 10.1159/000336423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117:285–297. doi: 10.1016/s0092-8674(04)00343-5. [DOI] [PubMed] [Google Scholar]
- 20.Scaccabarozzi A, Arosio P, Weiss G, Valenti L, Dongiovanni P, Fracanzani AL, Mattioli M, et al. Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br J Haematol. 2000;110:978–984. doi: 10.1046/j.1365-2141.2000.02280.x. [DOI] [PubMed] [Google Scholar]
- 21.Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood. 2003;101:4148–4154. doi: 10.1182/blood-2002-08-2459. [DOI] [PubMed] [Google Scholar]
- 22.Weiss G. Modification of iron regulation by the inflammatory response. Best Pract Res Clin Haematol. 2005;18:183–201. doi: 10.1016/j.beha.2004.09.001. [DOI] [PubMed] [Google Scholar]
- 23.Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, Nizet V. TLR-4 dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107:3727–3732. doi: 10.1182/blood-2005-06-2259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023. doi: 10.1056/NEJMra041809. [DOI] [PubMed] [Google Scholar]
- 25.Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093. doi: 10.1126/science.1104742. [DOI] [PubMed] [Google Scholar]
- 26.Weinberg ED. Patho-ecological implications of microbial acquisition of host iron. Reviews in Medical Microbiology. 1998;9:171–178. [Google Scholar]
- 27.Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009;113:5277–5286. doi: 10.1182/blood-2008-12-195651. [DOI] [PubMed] [Google Scholar]
- 28.Nairz M, Fritsche G, Crouch ML, Barton HC, Fang FC, Weiss G. Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition. Cell Microbiol. 2009;11:1365–1381. doi: 10.1111/j.1462-5822.2009.01337.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kim DK, Jeong JH, Lee JM, Kim KS, Park SH, Kim YD, Koh M, et al. Inverse agonist of estrogen-related receptor gamma controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med. 2014;20:419–424. doi: 10.1038/nm.3483. [DOI] [PubMed] [Google Scholar]
- 30.Nairz M, Schleicher U, Schroll A, Sonnweber T, Theurl I, Ludwiczek S, Talasz H, et al. Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med. 2013;210:855–873. doi: 10.1084/jem.20121946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432:917–921. doi: 10.1038/nature03104. [DOI] [PubMed] [Google Scholar]
- 32.Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2006;103:1834–1839. doi: 10.1073/pnas.0510847103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Deriu E, Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, Contreras H, Libby SJ, et al. Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe. 2013;14:26–37. doi: 10.1016/j.chom.2013.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Guglani L, Gopal R, Rangel-Moreno J, Junecko BF, Lin Y, Berger T, Mak TW, et al. Lipocalin 2 regulates inflammation during pulmonary mycobacterial infections. PLoS One. 2012;7:e50052. doi: 10.1371/journal.pone.0050052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Saiga H, Nishimura J, Kuwata H, Okuyama M, Matsumoto S, Sato S, Matsumoto M, et al. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol. 2008;181:8521–8527. doi: 10.4049/jimmunol.181.12.8521. [DOI] [PubMed] [Google Scholar]
- 36.Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure. 2005;13:29–41. doi: 10.1016/j.str.2004.10.009. [DOI] [PubMed] [Google Scholar]
- 37.Devireddy LR, Gazin C, Zhu X, Green MR. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell. 2005;123:1293–1305. doi: 10.1016/j.cell.2005.10.027. [DOI] [PubMed] [Google Scholar]
- 38.Devireddy LR, Hart DO, Goetz DH, Green MR. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell. 2010;141:1006–1017. doi: 10.1016/j.cell.2010.04.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Bao G, Clifton M, Hoette TM, Mori K, Deng SX, Qiu A, Viltard M, et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol. 2010;6:602–609. doi: 10.1038/nchembio.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Liu Z, Reba S, Chen WD, Porwal SK, Boom WH, Petersen RB, Rojas R, et al. Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection. J Exp Med. 2014;211:1197–1213. doi: 10.1084/jem.20132629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Nelson AL, Ratner AJ, Barasch J, Weiser JN. Interleukin-8 secretion in response to aferric enterobactin is potentiated by siderocalin. Infect Immun. 2007;75:3160–3168. doi: 10.1128/IAI.01719-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Schroll A, Eller K, Feistritzer C, Nairz M, Sonnweber T, Moser PA, Rosenkranz AR, et al. Lipocalin-2 ameliorates granulocyte functionality. Eur J Immunol. 2012;42:3346–3357. doi: 10.1002/eji.201142351. [DOI] [PubMed] [Google Scholar]
- 43.Liu Z, Petersen R, Devireddy L. Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections. J Immunol. 2013;190:4692–4706. doi: 10.4049/jimmunol.1202411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, Paixao TA, Butler BP, et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe. 2009;5:476–486. doi: 10.1016/j.chom.2009.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Cassat JE, Skaar EP. Iron in infection and immunity. Cell Host Microbe. 2013;13:509–519. doi: 10.1016/j.chom.2013.04.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta. 2012;1826:129–169. doi: 10.1016/j.bbcan.2012.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Borregaard N, Cowland JB. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals. 2006;19:211–215. doi: 10.1007/s10534-005-3251-7. [DOI] [PubMed] [Google Scholar]
- 48.Bellmann-Weiler R, Schroll A, Engl S, Nairz M, Talasz H, Seifert M, Weiss G. Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis. Immunobiology. 2013;218:969–978. doi: 10.1016/j.imbio.2012.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Warszawska JM, Gawish R, Sharif O, Sigel S, Doninger B, Lakovits K, Mesteri I, et al. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J Clin Invest. 2013;123:3363–3372. doi: 10.1172/JCI67911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Taub N, Nairz M, Hilber D, Hess MW, Weiss G, Huber LA. The late endosomal adaptor p14 is a macrophage host defense factor against Salmonella Typhimurium infection. J Cell Sci. 2012;125:2698–2708. doi: 10.1242/jcs.100073. [DOI] [PubMed] [Google Scholar]
- 51.Srinivasan G, Aitken JD, Zhang B, Carvalho FA, Chassaing B, Shashidharamurthy R, Borregaard N, et al. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. J Immunol. 2012;189:1911–1919. doi: 10.4049/jimmunol.1200892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Nairz M, Theurl I, Schroll A, Theurl M, Fritsche G, Lindner E, Seifert M, et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood. 2009;114:3642–3651. doi: 10.1182/blood-2009-05-223354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Bellmann-Weiler R, Martinz V, Kurz K, Engl S, Feistritzer C, Fuchs D, Rupp J, et al. Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma. Immunobiology. 2010;215:842–848. doi: 10.1016/j.imbio.2010.05.021. [DOI] [PubMed] [Google Scholar]
- 54.Theurl M, Theurl I, Hochegger K, Obrist P, Subramaniam N, van Rooijen N, Schuemann K, Weiss G. Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression. J Mol Med. 2008;86:825–835. doi: 10.1007/s00109-008-0346-y. [DOI] [PubMed] [Google Scholar]
- 55.Ludwiczek S, Theurl I, Artner-Dworzak E, Chorney M, Weiss G. Duodenal HFE expression and hepcidin levels determine body iron homeostasis: modulation by genetic diversity and dietary iron availability. J Mol Med. 2004;82:373–382. doi: 10.1007/s00109-004-0542-3. [DOI] [PubMed] [Google Scholar]
- 56.Schimanski LM, Drakesmith H, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood. 2005;105:4096–4102. doi: 10.1182/blood-2004-11-4502. [DOI] [PubMed] [Google Scholar]
- 57.Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263–274. doi: 10.1016/0092-8674(93)80068-p. [DOI] [PubMed] [Google Scholar]
- 58.Theurl I, Theurl M, Seifert M, Mair S, Nairz M, Rumpold H, Zoller H, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood. 2008;111:2392–2399. doi: 10.1182/blood-2007-05-090019. [DOI] [PubMed] [Google Scholar]
- 59.Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood. 2005;106:1092–1097. doi: 10.1182/blood-2005-02-0561. [DOI] [PubMed] [Google Scholar]
- 60.Mayr R, Griffiths WJ, Hermann M, McFarlane I, Halsall DJ, Finkenstedt A, Douds A, et al. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload. Gastroenterology. 2011;140:2056–2063. 2063 e2051. doi: 10.1053/j.gastro.2011.02.064. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.